CHARacterizing the cross-sectionaL approach to Ovarian cancer: geneTic TEsting of BRCA
Not Applicable
- Conditions
- The newly diagnosed patients with epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.
- Registration Number
- JPRN-UMIN000025597
- Lead Sponsor
- AstraZeneca K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1.In case of the subjects who are diagnosed to have acute or chronic physical or severe mental diseases except cancer, and about whom the attending responsible physician makes judgement to say that participation of these subjects would possibly increase the risks or would probably disturb the interpretation of the study results. 2.In case of the subjects whose registration for the study is judged by the attending responsible physician as inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method